Established in 1891, the Washington State Pharmacy Quality Assurance Commission (WA Pharmacy Commission) regulates the practice of pharmacy, and the distribution, manufacturing, and delivery of pharmaceuticals within and into the state. The commission protects and promotes public health and safety by issuing licenses, registrations, and certifications to qualified persons and entities and responding to complaints or reports of unprofessional conduct. The Commission is assigned the authority to enforce and change the schedule of controlled substances in Washington state.
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
Public
Structural Relationships
-
-
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
WA Pharmacy Commission - Information Set
- No information available at this time
Observations
The Week Ahead
(February 27, 2023)
After the house of origin fiscal committee cutoff, 18 cannabis bills remained active—one less than expected—as legislators prepared for floor debate over the next week and a half.
The Week Ahead
(January 30, 2023)
Hearings on WSLCB THC legislation, cannabis waste, advertising, low dose products, patient arrest protections, local override, home grow, and the fate of concentrates were all scheduled.
The Week Ahead
(January 23, 2023)
Legislators continued to undertake cannabis bills slowly, especially in the senate, but perennial subjects like out-of-state ownership had been positioned for consideration.
The Week Ahead
(March 7, 2022)
In the final week of a contentious short session, legislators would have to sprint to pass SB 5983, a bill to protect public health but also fundamentally restructure cannabis law.
The Week Ahead
(February 28, 2022)
Four synthesized cannabinoid regulation bills had been introduced after cutoff, cannabis-related amendments were in the operating budget, and new QC rules were imminent.
The Week Ahead
(February 21, 2022)
As the timeline for legislation became more compressed, committees crammed bills for action - while the WSLCB cannabinoid regulation bill was granted a second chance to NTIB.
The Week Ahead
(February 14, 2022)
By Tuesday evening, most bills would need to be voted out of their house of origin to continue, but three important—and contentious—cannabis-related bills remained unmoved.
The Week Ahead
(February 7, 2022)
After a brutal week for cannabis-related legislation which saw more than half rendered inactive, legislators prepared to undertake key debates on synthesized cannabinoids, community reinvestment, and social equity.
The Week Ahead
(January 31, 2022)
Policy committees rushed to recommend legislation ahead of the initial cutoff deadline on February 3rd, including bills on retail safety, cannabinoid regulation, and social equity.
The Week Ahead
(January 24, 2022)
24 cannabis-related bills were active and 11 were scheduled for committee activity in the week ahead, including social equity, craft endorsements, and WSLCB request legislation.